LENZ Therapeutics (LENZ) News Today → Bigger Than NVIDIA? (From Behind the Markets) (Ad) Free LENZ Stock Alerts $18.44 -0.10 (-0.54%) (As of 06/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 13, 2024 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Trading Down 1.4%LENZ Therapeutics (NASDAQ:LENZ) Shares Down 1.4%June 10, 2024 | globenewswire.comLENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024May 30, 2024 | globenewswire.comLENZ Therapeutics to Present at the Jefferies Global Healthcare ConferenceMay 15, 2024 | insidertrades.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Director James W. Mccollum Purchases 31,332 SharesMay 14, 2024 | marketbeat.comInsider Buying: LENZ Therapeutics, Inc. (NASDAQ:LENZ) Director Acquires 31,332 Shares of StockLENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) Director James W. Mccollum purchased 31,332 shares of the business's stock in a transaction on Monday, May 13th. The stock was purchased at an average cost of $15.99 per share, with a total value of $500,998.68. Following the acquisition, the director now owns 525,565 shares in the company, valued at $8,403,784.35. The purchase was disclosed in a legal filing with the SEC, which is available at this link.May 13, 2024 | seekingalpha.comLENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call TranscriptMay 12, 2024 | msn.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Q1 2024 Earnings Call TranscriptMay 10, 2024 | marketbeat.comLeerink Partnrs Weighs in on LENZ Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:LENZ)LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Stock analysts at Leerink Partnrs cut their FY2028 earnings estimates for shares of LENZ Therapeutics in a research note issued to investors on Wednesday, May 8th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post eMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for LENZ Therapeutics Amidst Strong Clinical Progress and Market PotentialMay 8, 2024 | globenewswire.comLENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 2, 2024 | marketbeat.comLENZ Therapeutics (LENZ) to Release Quarterly Earnings on WednesdayLENZ Therapeutics (NASDAQ:LENZ) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports.May 1, 2024 | globenewswire.comLENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024April 18, 2024 | morningstar.comLENZ Therapeutics IncApril 17, 2024 | marketbeat.comLENZ Therapeutics, Inc. to Post Q1 2024 Earnings of ($0.51) Per Share, Leerink Partnrs Forecasts (NASDAQ:LENZ)LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Investment analysts at Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for LENZ Therapeutics in a report released on Monday, April 15th. Leerink Partnrs analyst M. Goodman anticipates that the company will earn ($0.51)April 17, 2024 | marketbeat.comLENZ Therapeutics' (LENZ) "Outperform" Rating Reaffirmed at Leerink PartnrsLeerink Partnrs reaffirmed an "outperform" rating on shares of LENZ Therapeutics in a research note on Monday.April 15, 2024 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Receives New Coverage from Analysts at SVB LeerinkSVB Leerink initiated coverage on LENZ Therapeutics in a research report on Monday. They issued an "outperform" rating and a $32.00 price objective on the stock.April 14, 2024 | morningstar.comLENZ Therapeutics Inc LENZApril 10, 2024 | nasdaq.comLENZ Therapeutics, Inc. Common Stock (LENZ)April 10, 2024 | markets.businessinsider.comBlindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst SaysApril 10, 2024 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Now Covered by CitigroupCitigroup started coverage on LENZ Therapeutics in a research report on Wednesday. They set a "buy" rating and a $34.00 price objective for the company.April 3, 2024 | reuters.comLenz Therapeutics' eye disease drugs meet main goal of late-stage studyApril 3, 2024 | businesswire.comLENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia TrialsApril 2, 2024 | businesswire.comLENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia TrialsMarch 31, 2024 | 247wallst.comHuge Insider Buying From Buffett, an NFL Team Owner, a New CEOMarch 27, 2024 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Research Coverage Started at Piper SandlerPiper Sandler initiated coverage on shares of LENZ Therapeutics in a research note on Wednesday. They issued an "overweight" rating and a $28.00 price objective for the company.March 26, 2024 | insidertrades.comInsider Buying: LENZ Therapeutics, Inc. (NASDAQ:LENZ) Director Acquires 998,009 Shares of StockMarch 22, 2024 | marketbeat.comTrading was temporarily halted for "LENZ" at 09:03 AM with a stated reason of "LULD pause."March 22, 2024 | marketbeat.comTrading was temporarily halted for "LENZ" at 12:03 AM with a stated reason of "News pending." Trading set to resume at 03:03 AM. March 22, 2024 | marketbeat.comTrading was temporarily halted for "LENZ" at 03:03 AM with a stated reason of "News pending." Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Will this AI Micro-Cap be Bigger than NVIDIA? (Ad)With NVIDIA flying high, everyone is looking for the next breakout AI stock. But right now... There's only ONE AI stock you should be watching. Get the full story here >>> LENZ Media Mentions By Week LENZ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LENZ News Sentiment▼0.830.91▲Average Medical News Sentiment LENZ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LENZ Articles This Week▼22▲LENZ Articles Average Week Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CADL News Today IVVD News Today GLUE News Today SCLX News Today CHRS News Today ELEV News Today FENC News Today CGEN News Today ZURA News Today CMPX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LENZ) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored